Cargando…

IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis

Kawasaki disease (KD) vasculitis is an acute febrile illness of childhood characterized by systemic vasculitis of unknown origin, and is the most common cause of acquired heart disease among children in the United States. While histological evidence of myocarditis can be found in all patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gorelik, M., Lee, Y., Abe, M., Andrews, T., Davis, L., Patterson, J., Chen, S., Crother, T. R., Aune, G. J., Noval Rivas, M., Arditi, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718290/ https://www.ncbi.nlm.nih.gov/pubmed/31099056 http://dx.doi.org/10.1111/cei.13314

Ejemplares similares

Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate Vasculitis
por: Porritt, Rebecca A., et al.
Publicado: (2021)

Kawasaki disease: pathophysiology and insights from mouse models
por: Noval Rivas, Magali, et al.
Publicado: (2020)

Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis
por: Kocatürk, Begüm, et al.
Publicado: (2023)

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: Common Inflammatory Pathways of Two Distinct Diseases
por: Noval Rivas, Magali, et al.
Publicado: (2023)

Autophagy-mitophagy induction attenuates cardiovascular inflammation in a murine model of Kawasaki disease vasculitis
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2021)

MicroRNA-223 Regulates the Development of Cardiovascular Lesions in LCWE-Induced Murine Kawasaki Disease Vasculitis by Repressing the NLRP3 Inflammasome
por: Maruyama, Daisuke, et al.
Publicado: (2021)

Targeting IRE1 endoribonuclease activity alleviates cardiovascular lesions in a murine model of Kawasaki disease vasculitis
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2022)

Increased Myosin light chain 9 expression during Kawasaki disease vasculitis
por: Kobayashi, Hironobu, et al.
Publicado: (2023)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Familial mediterranean fever and pauciimmune renal vasculitis: the role of IL-1 blockade (Anakinra)
por: Lovillo, MS Camacho, et al.
Publicado: (2011)

Characterization of the T Cell Response to Lactobacillus casei Cell Wall Extract in Children With Kawasaki Disease and Its Potential Role in Vascular Inflammation
por: Hsieh, Li-En, et al.
Publicado: (2021)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
por: Hübner, Max, et al.
Publicado: (2020)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
por: Baskar, Shankar, et al.
Publicado: (2016)

Notch1 signaling impairs regulatory T cells during multisystem inflammatory syndrome in children
por: Noval Rivas, Magali, et al.
Publicado: (2023)

Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review
por: Ferrara, Giovanna, et al.
Publicado: (2020)

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes
por: Evans, Lucy P., et al.
Publicado: (2020)

Mitochondrial quality control in health and cardiovascular diseases
por: Atici, Asli E., et al.
Publicado: (2023)

Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis
por: Domiciano, Talita P., et al.
Publicado: (2017)

High dose anakinra for treatment of severe neonatal Kawasaki disease: a case report
por: Shafferman, Ashley, et al.
Publicado: (2014)

A child with resistant Kawasaki disease successfully treated with anakinra: a case report
por: Sánchez-Manubens, J., et al.
Publicado: (2017)

Resolution of Giant Coronary Aneurisms in a Child With Refractory Kawasaki Disease Treated With Anakinra
por: Gambacorta, Alessandro, et al.
Publicado: (2020)

Loss of testosterone impairs anti-tumor neutrophil function
por: Markman, Janet L., et al.
Publicado: (2020)

Kawasaki Disease Complicated with Cerebral Vasculitis and Severe Encephalitis
por: Stojanović, Vesna D, et al.
Publicado: (2020)

Kawasaki disease – A common childhood vasculitis
por: Sharma, Dhrubajyoti, et al.
Publicado: (2015)

Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Forever interesting disease: Kawasaki vasculitis – case series
por: Selmanovic, Velma, et al.
Publicado: (2014)

Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
por: Maier, André, et al.
Publicado: (2015)

Autophagy Protects Against Developing Increased Lung Permeability and Hypoxemia by Down Regulating Inflammasome Activity and IL-1β in LPS Plus Mechanical Ventilation-Induced Acute Lung Injury
por: Nosaka, Nobuyuki, et al.
Publicado: (2020)

Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
por: Bossi, Grazia, et al.
Publicado: (2022)

Anakinra treats fulminant myocarditis from Neisseria meningitidis septicaemia and haemophagocytic lymphohistiocytosis: a case report
por: Thomson, Ross J, et al.
Publicado: (2021)

Efficacy of sildenafil and high-dose anakinra in an MIS-C patient with pulmonary vasculitis: A case report
por: La Torre, Francesco, et al.
Publicado: (2023)

Kawasaki Disease Features and Myocarditis in a Patient with COVID-19
por: Chiu, Joanne S., et al.
Publicado: (2020)

Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
por: Cunha, Burke A., et al.
Publicado: (2010)

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis
por: Qiu, Yu, et al.
Publicado: (2022)

A pilot study of IL-1 inhibition by anakinra in acute gout
por: So, Alexander, et al.
Publicado: (2007)

Caspase-1 Dependent IL-1β Secretion Is Critical for Host Defense in a Mouse Model of Chlamydia pneumoniae Lung Infection
por: Shimada, Kenichi, et al.
Publicado: (2011)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
por: Vallejo, Susana, et al.
Publicado: (2014)

The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease
por: Hamaoka-Okamoto, Akiko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_sos2o33vs9oqbvu67f6tn7cele